efaproxiral has been researched along with paclitaxel in 1 studies
Studies (efaproxiral) | Trials (efaproxiral) | Recent Studies (post-2010) (efaproxiral) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
---|---|---|---|---|---|
76 | 13 | 10 | 31,874 | 5,729 | 15,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ayoub, J; Boyd, AP; Cagnoni, PJ; Choy, H; Curran, WJ; Hamburg, S; Kleinberg, L; Kreisman, H; Nabid, A; Roa, W; Scott, C; Smith, C; Souhami, L; Spanos, W; Stea, B | 1 |
1 trial(s) available for efaproxiral and paclitaxel
Article | Year |
---|---|
Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer.
Topics: Adult; Aged; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Propionates; Radiation-Sensitizing Agents; Survival Analysis | 2005 |